CY1111722T1 - Νεες ενωσεις κυκλοεξενονης απο antrodia camphorata και εφαρμογες αυτων - Google Patents

Νεες ενωσεις κυκλοεξενονης απο antrodia camphorata και εφαρμογες αυτων

Info

Publication number
CY1111722T1
CY1111722T1 CY20111100713T CY111100713T CY1111722T1 CY 1111722 T1 CY1111722 T1 CY 1111722T1 CY 20111100713 T CY20111100713 T CY 20111100713T CY 111100713 T CY111100713 T CY 111100713T CY 1111722 T1 CY1111722 T1 CY 1111722T1
Authority
CY
Cyprus
Prior art keywords
antrodia camphorata
cycloxenone
compounds
applications
new
Prior art date
Application number
CY20111100713T
Other languages
Greek (el)
English (en)
Inventor
Sheng-Yung Liu
Wu-Che Wen
Wan-Ling Tsou
Mao-Tien Kuo
Chun-Hung Huang
K-Heng Fok
Ya-Ying Li
Chung-Chou Chang
Original Assignee
Golden Biotechnology Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Golden Biotechnology Corporation filed Critical Golden Biotechnology Corporation
Publication of CY1111722T1 publication Critical patent/CY1111722T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
    • C07C403/02—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains containing only carbon and hydrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/074—Ganoderma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/308—Foods, ingredients or supplements having a functional effect on health having an effect on cancer prevention
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Fats And Perfumes (AREA)
CY20111100713T 2007-01-08 2011-07-20 Νεες ενωσεις κυκλοεξενονης απο antrodia camphorata και εφαρμογες αυτων CY1111722T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TW096100680A TW200829234A (en) 2007-01-08 2007-01-08 Antrodia camphorata isophorone extract
EP08250090A EP1942093B1 (en) 2007-01-08 2008-01-09 Novel cyclohexenone compounds from antrodia camphorata and application thereof

Publications (1)

Publication Number Publication Date
CY1111722T1 true CY1111722T1 (el) 2015-10-07

Family

ID=38219309

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20111100713T CY1111722T1 (el) 2007-01-08 2011-07-20 Νεες ενωσεις κυκλοεξενονης απο antrodia camphorata και εφαρμογες αυτων

Country Status (25)

Country Link
US (1) US7342137B1 (enExample)
EP (1) EP1942093B1 (enExample)
JP (1) JP5085186B2 (enExample)
KR (1) KR101011616B1 (enExample)
AR (1) AR064788A1 (enExample)
AT (1) ATE509005T1 (enExample)
AU (1) AU2008200063C1 (enExample)
BR (1) BRPI0800401A (enExample)
CA (1) CA2618271C (enExample)
CY (1) CY1111722T1 (enExample)
DE (1) DE102007022161A1 (enExample)
DK (1) DK1942093T5 (enExample)
ES (1) ES2365888T3 (enExample)
FR (1) FR2911133A1 (enExample)
GB (1) GB2445430A (enExample)
HR (1) HRP20110588T1 (enExample)
MY (1) MY144944A (enExample)
NO (1) NO20080078L (enExample)
NZ (1) NZ564913A (enExample)
PL (1) PL1942093T3 (enExample)
PT (1) PT1942093E (enExample)
SG (1) SG144815A1 (enExample)
SI (1) SI1942093T1 (enExample)
TW (1) TW200829234A (enExample)
ZA (1) ZA200800150B (enExample)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI394572B (zh) * 2007-06-12 2013-05-01 Golden Biotechnology Corp Application of Cynanchum aurantii Cyclohexenone Compounds in the Preparation of Drugs for the Treatment of Autoimmune Diseases
TWI394573B (zh) * 2007-06-14 2013-05-01 國鼎生物科技股份有限公司 Application of Cynanchum auranthone Cyclohexenone Compounds in the Preparation of Drugs for Liver Protection
CN101333156B (zh) * 2007-06-27 2011-07-20 国鼎生物科技股份有限公司 牛樟芝环己烯酮化合物的制备方法及其应用
TWI394575B (zh) * 2007-07-09 2013-05-01 Golden Biotechnology Corp Application of Cynanchum auranthone Cyclohexenone Compounds in the Preparation of Drugs for the Suppression of Hepatitis B Virus
JP5203644B2 (ja) * 2007-07-13 2013-06-05 國鼎生物科技股▲ふん▼有限公司 自己免疫疾病の治療に用いるベニクスノキタケ由来の化合物
JP5106935B2 (ja) * 2007-07-17 2012-12-26 國鼎生物科技股▲ふん▼有限公司 生理的疲労の緩和に用いるベニクスノキタケのシクロヘキサンケトン化合物
CN101357883B (zh) * 2007-07-30 2012-09-26 国鼎生物科技股份有限公司 治疗自体免疫疾病的牛樟芝环己烯酮化合物及医药组成物
CN101362679B (zh) * 2007-08-08 2012-05-30 国鼎生物科技股份有限公司 用于抑制b型肝炎病毒的牛樟芝环己烯酮化合物
CN101376624B (zh) * 2007-08-29 2011-06-01 国鼎生物科技股份有限公司 用于护肝的牛樟芝环己烯酮化合物
CN101417934B (zh) * 2007-10-24 2012-04-18 国鼎生物科技股份有限公司 分离自牛樟芝萃取物的化合物
TW201102076A (en) * 2009-07-09 2011-01-16 Golden Biotechnology Corp Cyclohexenone compound of Antrodia cinnomomea suppressing growth of tumor cell of osteosarcoma
TW201102075A (en) * 2009-07-09 2011-01-16 Golden Biotechnology Corp Cyclohexenone compound of Antrodia cinnomomea that suppresses growth of tumor cell of pancreatic cancer
TWI383790B (zh) * 2009-09-09 2013-02-01 國鼎生物科技股份有限公司 Used to inhibit the growth of oral cancer cells of the cattle Antrodylcyclohexenone compounds
TWI394566B (zh) * 2009-09-09 2013-05-01 國鼎生物科技股份有限公司 Used to inhibit the growth of ovarian cancer tumor cells of the cattle camphor cyclohexene ketone compounds
TW201109014A (en) * 2009-09-09 2011-03-16 Golden Biotechnology Corp Cyclohexenone compound of Antrodia cinnomomea that suppresses growth of tumor cell of skin cancer
TWI383791B (zh) * 2009-09-09 2013-02-01 國鼎生物科技股份有限公司 Used to inhibit the growth of gastric cancer tumor cells of the male antler ketone compounds
TW201109023A (en) * 2009-09-09 2011-03-16 Golden Biotechnology Corp Cyclohexenone compound of Antrodia cinnomomea that suppresses growth of tumor cell of colorectal cancer
TW201109024A (en) * 2009-09-09 2011-03-16 Golden Biotechnology Corp Cyclohexenone compound of Antrodia cinnomomea that suppresses growth of tumor cell of bladder cancer
TW201109013A (en) * 2009-09-09 2011-03-16 Golden Biotechnology Corp Cyclohexenone chemical compounds of Antrodia cinnamomea for suppressing the growth of the Lymphoma tumor cell
EP2329816B1 (en) 2009-11-26 2016-04-13 National Taiwan University An anti-cancer active substance from antrodia camphorata, method for preparing the same and use thereof
US8309611B2 (en) * 2010-09-20 2012-11-13 Golden Biotechnology Corporation Methods and compositions for treating lung cancer
TWI452032B (zh) 2011-01-21 2014-09-11 國鼎生物科技股份有限公司 治療腎病之醫藥組成物
CN103796647A (zh) * 2011-06-10 2014-05-14 国鼎生物科技股份有限公司 用于治疗脑癌的方法和组合物
SE1350211A1 (sv) 2012-02-23 2013-08-24 Golden Biotechnology Corp Metoder och kompositioner för behandling av cancermetastaser
JP6234990B2 (ja) * 2012-03-26 2017-11-22 ゴールデン バイオテクノロジー コーポレーション 動脈硬化性血管疾患を処置するための方法及び組成物
KR102088078B1 (ko) * 2012-11-21 2020-03-12 골든 바이오테크놀러지 코포레이션 신경퇴행성 질환을 치료하기 위한 방법 및 조성물
CN103058846B (zh) * 2013-01-17 2014-07-30 福州大学 一种源于棘孢曲霉的苯醌衍生物及其应用
TWI612026B (zh) * 2013-02-20 2018-01-21 國鼎生物科技股份有限公司 環己烯酮組成物及其製造方法
US20150018296A1 (en) * 2013-03-15 2015-01-15 Golden Biotechnology Corporation Therapeutic methods and compositions utilizing cyclohexenone compounds
TWI583376B (zh) * 2013-03-20 2017-05-21 曾卉菱 Compounds isolated from Antelroxicus and their use
TW201521752A (zh) * 2013-12-05 2015-06-16 國立臺灣師範大學 牛樟芝於抗肥胖的應用及其方法
EP3082779B1 (en) * 2013-12-20 2023-06-07 Biomed Valley Discoveries, Inc. Cancer treatments using combinations of type 2 mek and erk inhibitors
CN104522794B (zh) * 2014-12-04 2017-01-11 深圳市仁泰生物科技有限公司 樟芝解毒饮料及其制备方法
PL3240772T3 (pl) * 2014-12-30 2021-06-28 ONENESS BIOTECH CO., Ltd Związki z antrodia camphorata, sposoby ich otrzymywania i ich zastosowanie
TWI637746B (zh) * 2016-01-20 2018-10-11 台灣利得生物科技股份有限公司 固態培養牛樟芝菌絲體及子實體萃取物之組合物作為腫瘤抑制劑之應用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3064012A (en) * 1960-07-20 1962-11-13 Merck & Co Inc Derivatives of coenzyme q10
WO1986003738A1 (en) * 1984-12-17 1986-07-03 Snader Kenneth M Antiviral and antitumor cyclohexadienone compositions
TWI226370B (en) * 2000-02-17 2005-01-11 Food Industry Res & Dev Inst Isolate of Antrodia camphorata, process for producing a culture of the same and product obtained thereby
US6767543B2 (en) * 2000-02-17 2004-07-27 Council Of Agriculture, Executive Yuan Process for producing a culture of Antrodia camphorata and product obtained thereby
JP5403844B2 (ja) * 2004-03-02 2014-01-29 善笙生物科技股▲分▼有限公司 ＡｎｔｒｏｄｉａＣａｍｐｈｏｒａｔａの菌糸体から得た新規な混合物及び化合物、並びにその使用
US7109232B2 (en) * 2004-03-08 2006-09-19 Simpson Biotech Co., Ltd. Compounds from Antrodia camphorata having anti-inflammatory and anti-tumor activity
TW200638867A (en) * 2005-05-06 2006-11-16 Golden Biotechnology Corp Incubation and application methods for the culture of antrodia camphorata
US20070116787A1 (en) * 2005-11-21 2007-05-24 Chih-Jung Yao Cancer treatment

Also Published As

Publication number Publication date
GB2445430A (en) 2008-07-09
AR064788A1 (es) 2009-04-22
TW200829234A (en) 2008-07-16
US7342137B1 (en) 2008-03-11
GB0709171D0 (en) 2007-06-20
BRPI0800401A (pt) 2008-08-26
PT1942093E (pt) 2011-08-23
AU2008200063A1 (en) 2008-07-24
EP1942093A1 (en) 2008-07-09
EP1942093B1 (en) 2011-05-11
SG144815A1 (en) 2008-08-28
NZ564913A (en) 2009-05-31
JP5085186B2 (ja) 2012-11-28
NO20080078L (no) 2008-07-09
KR20080065218A (ko) 2008-07-11
DK1942093T5 (da) 2012-04-02
HRP20110588T1 (hr) 2011-11-30
ATE509005T1 (de) 2011-05-15
ES2365888T3 (es) 2011-10-13
SI1942093T1 (sl) 2012-01-31
AU2008200063B2 (en) 2010-01-07
PL1942093T3 (pl) 2011-10-31
AU2008200063C1 (en) 2011-05-19
CA2618271C (en) 2010-08-31
MY144944A (en) 2011-11-30
DE102007022161A1 (de) 2008-07-10
FR2911133A1 (fr) 2008-07-11
JP2008169194A (ja) 2008-07-24
KR101011616B1 (ko) 2011-01-27
TWI330528B (enExample) 2010-09-21
CA2618271A1 (en) 2008-07-08
DK1942093T3 (da) 2011-08-29
ZA200800150B (en) 2009-08-26

Similar Documents

Publication Publication Date Title
CY1111722T1 (el) Νεες ενωσεις κυκλοεξενονης απο antrodia camphorata και εφαρμογες αυτων
UA97135C2 (en) Cyclohexenone extractant of antrodia camphorata
Shaaban et al. Synthesis and biochemical studies of novel organic selenides with increased selectivity for hepatocellular carcinoma and breast adenocarcinoma
BR112012000968B8 (pt) composto, composição e método para inibir uma fosfatidil inositol-3 cinase.
PH12015501464A1 (en) Histone demethylase inhibitors
TN2011000053A1 (en) Organic compounds
MY157124A (en) Substituted imidazopyridinyl-aminopyridine compounds
BR112012019762A2 (pt) composto, composição, e, método para tratar uma doença.
MX2015007205A (es) Inhibidores de la desmetilasa de histona.
BR112018067775A2 (pt) inibidores de mcl-1 indol substituído
WO2011082273A3 (en) Substituted pyrrolo-aminopyrimidine compounds
BR0308908A (pt) Composto, composição, uso de um composto, e, métodos para inibir a hdac em uma célula, para o tratamento de uma condição mediada pela hdac, de um condição proliferativa, de câncer e de psorìase
WO2011082267A3 (en) Substituted triazolo-pyrazine compounds
WO2013061004A8 (fr) Nouveaux composés di-substitués de la diamino-3,4-cyclobutène-3-dione-1,2 utiles dans le traitement de pathologies médiées par des chimiokines
WO2012138907A3 (en) Solid forms of curcumin
NZ629898A (en) Compositions and methods for inhibition of cathepsins
WO2011082268A3 (en) Substituted naphthalenyl-pyrimidine compounds
BR112022012149A2 (pt) Síntese de compostos para promover o crescimento do cabelo
MX341211B (es) Sintesis de un nuevo antioxidante de nitroxido y metodos de uso en composiciones cosmeticas y dermatologicas.
BR112012021680A2 (pt) composição de controle de doença de planta e método para controlar doença de planta.
MX347677B (es) Formulacion farmaceutica entre jasmonatos y sus derivados y nanoportadores o microportadores.
WO2010034006A3 (en) The putative tumor suppressor microrna-101 modulates the cancer epigenome by repressing the polycomb group protein ezh2.
IL184292A0 (en) Treatment of drug-resistant proliferative disorders
MX2025003004A (es) Formas farmaceuticas de un inhibidor de cd73
BRPI0508232A (pt) sìntese de epotilonas, intermediários das mesmas, análogos e usos das mesmas